HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or b.
about
Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trial.Antiproliferative, antibacterial and antifungal activity of the lichen Xanthoria parietina and its secondary metabolite parietin.miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancerDetection of Exosomal miRNAs in the Plasma of Melanoma Patients.Histone deacetylases and mechanisms of regulation of gene expressionMicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat.Overexpression of microRNA-196b Accelerates Invasiveness of Cancer Cells in Recurrent Epithelial Ovarian Cancer Through Regulation of Homeobox A9.Histone deacetylation meets miRNA: epigenetics and post-transcriptional regulation in cancer and chronic diseases.Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review.MicroRNA: an important regulator in acute myeloid leukemia.miR-194-5p/BCLAF1 deregulation in AML tumorigenesis.Dualistic Role of BARD1 in Cancer.CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles.miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer
P2860
Q33439523-910881DE-4349-40BE-AC43-92631DB04F52Q34471130-480ABCEE-1A5D-4AE1-B843-7BB95D4EEEB6Q34544501-4EECA446-1CCE-41ED-99D6-677E22C2B780Q36409368-050FEABB-37B7-493C-B95C-9F12531E4AE1Q36734390-DCD7EF70-A24D-4F17-9B1D-88AF0119657BQ37641769-33B42162-6EC7-4EFE-B4A5-8DEE9BABBB55Q37724888-4F624430-07E9-4776-8111-FEEA09806A39Q38376048-11E14781-021E-4592-B4EE-F9272BC19859Q38572855-6E284306-660E-4763-B683-A5D253BF18A8Q38735859-DE35C2AB-CFC4-4DA3-86F8-AF3ADA942320Q44599122-60D460F8-DE92-484F-9853-B28F4C68099EQ47177315-260ED492-B15F-4527-B513-085B4DDE08F1Q47347862-5053D3E9-8939-4D58-919D-B1603B7B079CQ58799032-7449533B-C539-4562-B2CB-8884727C8495
P2860
HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or b.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
HDAC inhibitors repress BARD1 ...... ctivation of miR-19a and/or b.
@ast
HDAC inhibitors repress BARD1 ...... ctivation of miR-19a and/or b.
@en
type
label
HDAC inhibitors repress BARD1 ...... ctivation of miR-19a and/or b.
@ast
HDAC inhibitors repress BARD1 ...... ctivation of miR-19a and/or b.
@en
prefLabel
HDAC inhibitors repress BARD1 ...... ctivation of miR-19a and/or b.
@ast
HDAC inhibitors repress BARD1 ...... ctivation of miR-19a and/or b.
@en
P2093
P2860
P50
P1433
P1476
HDAC inhibitors repress BARD1 ...... ctivation of miR-19a and/or b.
@en
P2093
Felicetto Ferrara
Floriana De Bellis
Francesco P Tambaro
Guillermo Garcia-Manero
Ilaria Lepore
Irmgard Irminger-Finger
Maxim Pilyugin
Tiziana Izzo
P2860
P304
P356
10.1371/JOURNAL.PONE.0083018
P407
P577
2013-12-11T00:00:00Z